Splicing Factor, Arginine/serine-Rich 3 (SFRS3) Antibody

REQUEST MORE INFO
Catalogue No: abx028702
Price: US$326.25
(Size: 80 µl)

Click on the image to see the image legend

Available Options

* Size:


Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
SFRS3 is a member of the serine/arginine (SR) rich family of pre-mRNA splicing factors, which constitute part of the spliceosome. Each of these factors contains an RNA recognition motif (RRM) for binding RNA and an RS domain for binding other proteins. The RS domain is rich in serine and arginine residues and facilitates interaction between different SR splicing factors. In addition to being critical for mRNA splicing, the SR proteins have also been shown to be involved in mRNA export from the nucleus and in translation. Two transcript variants, one protein-coding and the other non-coding, have been found for this gene.

Target Splicing Factor, Arginine/serine-Rich 3 (SFRS3)
Clonality Polyclonal
Reactivity Human
Tested Applications ELISA, WB
Host Rabbit
Recommended dilutions WB: 1/1000. Optimal dilutions/concentrations should be determined by the end user.
Conjugation Unconjugated
Immunogen KLH-conjugated synthetic peptide between 82-110 amino acids from the Central region of human SFRS3.
Isotype IgG
Form Liquid
Purification Purified through a protein A column, followed by peptide affinity purification.
Storage Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
UniProt Primary AC P84103 (UniProt, ExPASy)
UniProt Secondary AC B4E241, O08831, P23152, Q5R3K0
UniProt Entry Name SRSF3_HUMAN
KEGG hsa:6428
String 9606.ENSP00000362820
Molecular Weight Calculated MW: 19.3 kDa
Buffer PBS containing 0.09% sodium azide.
Specificity Predicted to react with Mouse and Cow SRSF3.
Availability Shipped within 5-10 working days.
Note THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Research Articles on Splicing Factor, Arginine/serine-Rich 3 (SFRS3)


Write a review